These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8847017)

  • 21. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
    Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
    Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.
    Schniewind B; Bestmann B; Kurdow R; Tepel J; Henne-Bruns D; Faendrich F; Kremer B; Kuechler T
    Ann Surg Oncol; 2006 Nov; 13(11):1403-11. PubMed ID: 17009141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
    Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
    Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.
    Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL
    Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumours.
    Lygidakis NJ; Savanis G; Pothoulakis J; Kapetanakis A
    Anticancer Res; 1994; 14(2B):643-6. PubMed ID: 8010721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
    Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
    Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].
    Popiela T; Kedra B; Sierzega M; Kubisz A
    Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline.
    Fujino Y; Suzuki Y; Ajiki T; Tanioka Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2003; 50(49):250-3. PubMed ID: 12630033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.
    Maire F; Hammel P; Ponsot P; Aubert A; O'Toole D; Hentic O; Levy P; Ruszniewski P
    Am J Gastroenterol; 2006 Apr; 101(4):735-42. PubMed ID: 16635221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy-centered multimodal treatment of unresectable pancreatic carcinoma.
    Kojima Y; Kimura T; Yasukawa H; Katayama K; Note M; Isobe Y; Fujita H; Nakagawara G; Nakatsugawa S; Shiraishi T
    Int Surg; 1991; 76(2):87-90. PubMed ID: 1714424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting locoregional immunochemotherapy with new drugs in metastatic liver disease: a promising alternative.
    Lygidakis NJ; Berberabe AE; Spentzouris N; Dedemadi G; Kalligas T; Loukas G; Sotiropoulou B
    Hepatogastroenterology; 1998; 45(24):2248-51. PubMed ID: 9951904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Palliative treatment for unresectable cases of pancreatic carcinoma].
    Hasegawa H; Nimura Y; Hayakawa N; Kamiya J; Maeda S; Okamoto K; Shionoya S
    Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1625-31. PubMed ID: 2418343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of late-staged pancreatic carcinoma with implantation of 125I seeds in combination with regional arterial infusion chemotherapy].
    Ai KX; Zheng Q; Xia Y; Huang XY; Zou JH; Yan J; Mao JY
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):27-9. PubMed ID: 17403285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.